Trials / Completed
CompletedNCT04715126
Evaluate Efficacy of Oxyjun on Cardiovascular Health in Healthy Individuals.
A Randomized, Placebo-controlled, Blinded Study to Evaluate Efficacy of Oxyjun on Cardiovascular Health in Healthy Individuals.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Terminalia arjuna, commonly known as arjuna, that belongs to the family of Combretaceae. Most clinical and experimental studies for Terminalia arjuna, have suggested that the crude drug possesses anti-ischemic, antioxidant, hypolipidemic, and antiatherogenic activities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oxyjun | One capsule to be taken after breakfast with water. |
| OTHER | Placebo | One capsule to be taken after breakfast with water. |
Timeline
- Start date
- 2021-01-11
- Primary completion
- 2021-09-02
- Completion
- 2021-09-02
- First posted
- 2021-01-20
- Last updated
- 2021-11-17
Locations
4 sites across 1 country: India
Source: ClinicalTrials.gov record NCT04715126. Inclusion in this directory is not an endorsement.